Phesgo 600mg/600mg/20.000 units s.c. sol. for inj. 10 ml Online Shopping
التصنيف: antineoplastic المادة الفعالة:pertuzumab+trastuzumab+hyaluronidase
indications: 1-early breast cancer. phesgoï- (pertuzumab trastuzumab and hyaluronidase-zzxf) is indicated for use in combination with chemotherapy for **the neoadjuvant treatment of adult patients with her2-positive locally advanced inflammatory or early
